Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,460 | -1,494 | -1,113 | -1,523 | -855 |
| Depreciation Amortization | 366 | 242 | 120 | 39 | 39 |
| Accounts receivable | 1,007 | -1,739 | -2,425 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,174 | 1,856 | 2,176 | 552 | 385 |
| Other Working Capital | 2,181 | 117 | -249 | 272 | 454 |
| Other Operating Activity | -2,181 | -117 | 249 | -426 | -322 |
| Operating Cash Flow | $1,087 | $-1,135 | $-1,242 | $-1,086 | $-299 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -101 | -121 | -100 | N/A | N/A |
| Investing Cash Flow | $-101 | $-121 | $-100 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -164 | 1,791 | 1,614 | 50 | 50 |
| Debt Repayment | -852 | -580 | -289 | N/A | N/A |
| Other Financing Activity | -8 | -6 | -4 | 0 | 0 |
| Financing Cash Flow | $-1,024 | $1,205 | $1,321 | $50 | $50 |
| Beginning Cash Position | 51 | 51 | 51 | 1,341 | 1,341 |
| End Cash Position | 13 | N/A | 30 | 305 | 1,092 |
| Net Cash Flow | $-38 | $-51 | $-21 | $-1,036 | $-249 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,087 | -1,135 | -1,242 | -1,086 | -299 |
| Capital Expenditure | -101 | -121 | -100 | N/A | N/A |
| Free Cash Flow | 986 | -1,256 | -1,342 | -1,086 | -299 |